Rheumatoid Arthritis

Leflunomide, marketed under the brand name Arava, is a safe and effective treatment for early rheumatoid arthritis, according to a study in International Journal of Rheumatic Diseases.

In rheumatoid arthritis there is an ongoing debate about what to do when methotrexate fails. Physicians typically have two choices.

Biologics can improve the quality of life for RA patients, but side effects remain a problem, especially for RA patients with co-morbidities.

A systematic review of alopecia areata (AA) in Clinical, Cosmetic & Investigational Dermatology highlighted the unpredictability and lack of treatment options for the condition. But it also pointed to a larger problem: more than half of patients with AA experience poor health-related quality of life (QOL). Patients with AA are at risk for depression and anxiety, atopy, vitiligo, thyroid disease, and other autoimmune conditions.

Treatment for rheumatoid arthritis may be delivered like a vaccine, according to findings from Science Translational Medicine.

Half of the patients with psoriatic arthritis enrolled in a trial of etanercept continued responding to the medication and complying with treatment guidelines for more than 5 years.

In autoimmune diseases, one size doesn't fit all when it comes to tools to encourage adherence to treatment..

The number of opioid-related deaths nearly quadrupled from 1999 to 2011 in the US; and while that number continues to increase, one state has made positive strides with the implementation of two initiatives.

Treatment options for rheumatoid arthritis (RA) have undergone an explosion in choice over the past 25 years and researchers recently analyzed a new combination therapy.

Cardiovascular disease is the most common comorbidity in patients with rheumatoid arthritis (RA) and the reason behind it may have finally been identified.

Biologics for systemic juvenile idiopathic arthritis lead to inactive disease status and remission for some patients.

A $102 test could be the crux between good health and a future of chronic illness for patients with rheumatoid arthritis.

Rheumatoid arthritis therapy that focuses on early and more intensive treatment produces DMARD-free sustained remission, according to findings from researchers at the Karolinska Institutet.

Patients with tophaceous gout rarely develop ulcers, but when they do occur, these ulcers can be difficult to treat. This case study explores the diagnosis of and treatment options for patients with ulcerated tophaceous gout.

As the population ages and medicine continues to advance, people are living longer and healthier; but they are also taking more medications for more medical conditions. Those medications can cause drug-drug interactions that lead to adverse drug reactions (ADR). Studies have shown that the majority of medication errors happen at the stage of prescription.

Tumor necrosis factor-a inhibitors are the most widely used first line biologic therapy for the treatment of rheumatoid arthritis, but there have been concerns raised about the safety of these treatments.

Advances in genomic study are enabling researchers to narrow down the specific alleles that may contribute most heavily to the epigenetic reasons behind giant cell arteritis and other rheumatic conditions.

Researchers from Children’s Hospital of Philadelphia suggest that rheumatologists consider screening children with juvenile spondyloarthritis for sacroiliitis, but especially children who carry the HLA-B27 gene form of the disease with elevated C-reactive protein levels.

Many patients with rheumatoid arthritis (RA) who smoke use it as a distraction from the pain associated with their condition and as a coping mechanism for dealing with the frustrations of living with RA.

Rheumatoid arthritis patients with sustained moderate disease, despite two-three years of methotrexate treatment, are at risk for significant radiographic progression, a new study shows.

The understanding of the inflammatory processes contributing to rheumatoid arthritis continues to grow, leading to greater understanding of RA and improved diagnostic tools and medications.

When severe joint damage is present, total knee arthroplasty (TKA) surgery may be the best approach to regain comfort and function. Researchers analyzed procedure outcomes in two groups of patients.

Cardiorespiratory fitness is low among patients with rheumatoid arthritis. Improving fitness improves risks for cardiovascular disease and coupled with combination therapy, may lower disease activity as well as foster increased physical activity, recent studies show.

A new review points to important questions about the efficacy and safety of paracetamol (acetaminophen) to treat spinal pain and osteoarthrisis.

Researchers have identified a novel chemical compound that can reduce the severity of rheumatoid arthritis symptoms, according to researchers from Montana State University.

Although many patients with arthritis have a difficult time engaging in high-intensity exercises, that may be the very thing they need to reduce their risk for cardiovascular complications associated with the disease.

Little is known about the etiology of juvenile idiopathic arthritis, but now a new study shows an association between antibiotic use and newly diagnosed cases of JIA.

Clinical trial of 120 RA patients shows that adalimumab (Exemptia) works as well as adalimumab (Humira).

Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.